PulseAugur
EN
LIVE 23:38:27

AI adoption expands in SMEs and drug discovery

Small and medium-sized enterprises (SMEs) are increasingly leveraging AI to automate tasks, enhance decision-making, and allocate more resources to strategic growth. This shift involves delegating work not only to human employees but also to AI systems. In parallel, the life sciences sector is seeing AI transition from theoretical concepts to practical applications, particularly in drug discovery, where it accelerates research workflows. AI

IMPACT AI is becoming a key tool for business automation and strategic growth in SMEs, while also accelerating practical applications in drug discovery.

RANK_REASON The cluster consists of opinion pieces and feature articles discussing the application of AI in business and life sciences, rather than a primary release or significant event.

Read on Mastodon — mastodon.social →

AI-generated summary · Google Gemini · from 2 sources. How we write summaries →

AI adoption expands in SMEs and drug discovery

COVERAGE [2]

  1. Mastodon — mastodon.social TIER_1 English(EN) · TechFinitive ·

    Growing a business isn't about doing everything yourself. Our latest feature explores how SMEs are using AI to automate routine work, improve decision-making an

    Growing a business isn't about doing everything yourself. Our latest feature explores how SMEs are using AI to automate routine work, improve decision-making and free up time for strategy and growth. Featuring insights from Embridge Consulting, Clear Strategy, ScreenHits TV and I…

  2. Mastodon — mastodon.social TIER_1 English(EN) · TechFinitive ·

    As part of our The Future of Life Sciences R&D series, Cameron Ross, SVP of Generative AI at Elsevier, explores how AI is moving from theory to practical applic

    As part of our The Future of Life Sciences R&D series, Cameron Ross, SVP of Generative AI at Elsevier, explores how AI is moving from theory to practical application in drug discovery. He examines how AI is accelerating research workflows while arguing that trusted data, explaina…